Andrew McDonald

Andrew McDonald
Assistant Professor

Associate Scientist (C), O'Neal Comprehensive Cancer Center , School of Medicine
Assistant Professor (P), Radiation Oncology , School of Medicine
Associate Scientist, Cancer Control and Population Sciences , O'Neal Comprehensive Cancer Center
Associate Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center

Overview

I am an Assistant Professor of Radiation Oncology at the University of Alabama at Birmingham and am a member of the UAB Institute for Cancer Outcomes and Survivorship. My clinical specialization in genitourinary and gastrointestinal cancer and my clinician scientist focus is on mitigating treatment related toxicity in cancer survivors.

Selected Publications

Academic Article

Year	Title	Altmetric
2022	Association between body composition and chemotherapy-related toxicity in children with lymphoma and rhabdomyosarcoma. Cancer. 128:1302-1311. 2022
2021	Stereotactic body radiation therapy with simultaneous integrated boost for prostate cancer: does MRI-targeted biopsy alter the boost field? 2021
2021	Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis. Clinical Lung Cancer. 22:e716-e722. 2021
2021	Utility of ¹⁸F-fluciclovine PET/MRI for staging newly diagnosed high-risk prostate cancer and evaluating response to initial androgen deprivation therapy: A prospective single-arm pilot study. American Journal of Roentgenology. 217:720-729. 2021
2021	Why an Increasing Number of Unmatched Residency Positions in Radiation Oncology? A Survey of Fourth-Year Medical Students. Advances in Radiation Oncology. 6. 2021
2021	Association between chronologic age and geriatric assessment⇓identified impairments: Findings from the CARE registry. Journal of the National Comprehensive Cancer Network : JNCCN. 19:922-927. 2021
2021	Depression among older adults with gastrointestinal malignancies. Journal of Geriatric Oncology. 12:599-604. 2021
2021	Synchronous Malignancies Identified by ¹⁸F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review. Clinical Genitourinary Cancer. 19:e37-e40. 2021
2021	Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer. Supportive Care in Cancer. 29:263-269. 2021
2021	Students’ Perspectives and Concerns for the 2020 to 2021 Radiation Oncology Interview Season. Advances in Radiation Oncology. 6. 2021
2020	Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study. Archives of Osteoporosis. 15. 2020
2020	Controlling heterogeneity within the lymphatic target volume for dose painted treatment of prostate cancer. Medical Dosimetry. 45:202-205. 2020
2020	Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis– Results from the Cancer & Aging Resilience Evaluation (CARE) study. Journal of Geriatric Oncology. 11:982-988. 2020
2020	Assessment of Sarcopenia Measures, Survival, and Disability in Older Adults Before and After Diagnosis With Cancer. JAMA Network Open. 3:e204783. 2020
2020	Metastatic prostate cancer to an ischiorectal fossa lymph node identified on multiparametric magnetic resonance imaging. Urology Annals. 12:172-175. 2020
2020	Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE). Journal of Geriatric Oncology. 11:270-273. 2020
2020	Anchored Transponder Guided Lung Radiation Therapy. Practical Radiation Oncology. 10:e37-e44. 2020
2020	Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease. Advances in Radiation Oncology. 5:34-42. 2020
2020	Total body irradiation and risk of breast cancer after blood or marrow transplantation: A blood or marrow transplantation survivor study report. Journal of Clinical Oncology. 38:2872-2882. 2020
2019	Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma. Practical Radiation Oncology. 9:426-434. 2019
2019	Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic Malignancies. Practical Radiation Oncology. 9:456-464. 2019
2019	Feasibility of Dose Escalating [¹⁸F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer. Advances in Radiation Oncology. 4:649-658. 2019
2019	Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience. Annals of Oncology. 30:iv89. 2019
2019	Sarcopenia & aging in cancer. Journal of Geriatric Oncology. 10:374-377. 2019
2019	Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center. Journal of the American College of Radiology. 16:315-320. 2019
2019	Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection 2019
2019	Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implications. International Journal of Gynecological Cancer. 29:48-52. 2019
2019	Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy. Journal of Applied Clinical Medical Physics. 20:17-22. 2019
2019	Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial. Advances in Radiation Oncology. 4:90-95. 2019
2018	How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?. Urology. 122:139-146. 2018
2018	Brain dosimetry from locally advanced head and neck cancer radiotherapy: implications for neurocognitive outcomes research. Acta Oncologica. 57:1589-1592. 2018
2018	Dynamics of the vaginal wall dose in HDR interstitial brachytherapy for gynecological cancer: Systematic analysis of phantom vs patient case. Medical Dosimetry. 43:237-242. 2018
2017	Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer. Urologic Oncology: seminars and original investigations. 35:663.e15-663.e21. 2017
2017	Fractionated stereotactic radiation therapy for intact brain metastases. Advances in Radiation Oncology. 2:564-571. 2017
2017	Gait Speed and Survival in Patients With Brain Metastases. Journal of Pain and Symptom Management. 54:105-109. 2017
2017	CT measures of bone mineral density and muscle mass can Be used to predict noncancer death in men with prostate cancer. Radiology. 282:475-483. 2017
2017	Distant brain recurrence in patients with five or more newly diagnosed brain metastases treated with focal stereotactic radiotherapy alone.. Journal of Radiosurgery and SBRT. 4:255-263. 2017
2016	Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck. Journal of radiation oncology. 5:363-369. 2016
2016	Mesorectal node metastasis from gynecological cancer in the era of 3D conformal pelvic radiation therapy and intensity modulated radiation therapy. Practical Radiation Oncology. 6:402-404. 2016
2016	Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate Cancer. Journal of Clinical Densitometry. 19:430-435. 2016
2016	Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma 2016
2016	Evaluating the Role of Urinalysis for Suspected Cystitis in Women Undergoing Pelvic Radiotherapy.. International Journal of Gynecological Cancer. 2016
2016	Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies. World Journal of Gastroenterology. 22:3006-3014. 2016
2016	Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinoma. Prostate Cancer. 2016. 2016
2015	Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone. Journal of Gastrointestinal Cancer. 46:149-155. 2015
2014	Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: The University of Alabama at Birmingham experience. Neuro-oncology practice. 1:172-177. 2014
2014	Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy. Urology. 84:1383-1388. 2014
2014	Reply. Urology. 84:1388. 2014
2014	An empirical assessment of two-dimensional (2D) Debye-Scherrer-type image-plate X-ray diffraction data collapsed into a 1D diffractogram. Powder Diffraction. 29:337-345. 2014
2014	Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiation Oncology. 9. 2014
2014	PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation. Urologic Oncology: seminars and original investigations. 32:687-693. 2014
2013	Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer. Acta Oncologica. 52:1181-1188. 2013
2013	Patient benefit from salvage radiation for prostate cancer.. Journal of Clinical Oncology. 31:175. 2013
2013	Spontaneous spinal epidural abscess presenting in a previously healthy young adult man. Case Reports in Medicine. 2013. 2013
2012	Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.. Prostate Cancer. 2012:546794. 2012
2011	Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.. Journal of Clinical Oncology. 29:85. 2011